Dashboard
Manage Tickers

VVOS Vivos Therapeutics, Inc.

Nasdaq vivos.com


$ 3.12 $ -0.04 (-1.27 %)    

Thursday, 16-Oct-2025 10:53:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 606.21 $ 0.94 (0.16 %)
DIA $ 463.94 $ 0.57 (0.12 %)
SPY $ 667.26 $ 0.38 (0.06 %)
TLT $ 90.67 $ 0.17 (0.19 %)
GLD $ 392.93 $ 1.81 (0.46 %)
$ 3.15
$ 3.16
$ 3.10 x 1
$ 3.15 x 2,900
$ 3.12 - $ 3.17
$ 1.98 - $ 7.95
179,065
na
23.64M
$ 3.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 08-16-2023 06-30-2023 10-Q
9 06-08-2023 03-31-2023 10-Q
10 03-30-2023 12-31-2022 10-K
11 12-20-2022 09-30-2022 10-Q
12 12-20-2022 06-30-2022 10-Q
13 05-16-2022 03-31-2022 10-Q
14 03-31-2022 12-31-2021 10-K
15 11-15-2021 09-30-2021 10-Q
16 08-12-2021 06-30-2021 10-Q
17 05-17-2021 03-31-2021 10-Q
18 03-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vivos-study-demonstrates-its-daytime-nighttime-appliance-provides-relief-quality-of-life-improvement-in-children-with-attention-deficithyperactivity-disorder-obstructive-sleep-apnea
Vivos' Study Demonstrates Its Daytime-Nigh...
09/30/2025 12:41:30

Previously Unpublished Data Confirms Vivos DNA Devices Offer a Safe and Effective Alternative Treatment for Children with ADHD ...

vivos-therapeutics-announces-peer-reviewed-published-data-confirming-that-vivos-dna-is-both-safe-and-efficacious-in-treating-children-suffering-from-osa
Vivos Therapeutics Announces Peer-Reviewed...
09/17/2025 12:34:05

Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and technology...

ascendiant-capital-maintains-buy-on-vivos-therapeutics-raises-price-target-to-65
Ascendiant Capital Maintains Buy on Vivos ...
09/09/2025 11:18:43

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and raises the price target from...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/22/2025 21:07:35

vivos-therapeutics-q2-eps-055-misses-035-estimate-sales-3820m-beat-3783m-estimate
Vivos Therapeutics Q2 EPS $(0.55) Misses $...
08/19/2025 20:23:09

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of ...

reported-on-august-14-vivos-therapeutics-announces-co-is-unable-to-file-its-form-10-q-for-the-quarter-ended-june-30-2025-within-the-prescribed-time-period
Reported On August 14: Vivos Therapeutics ...
08/15/2025 16:39:04

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 17:05:56

vivos-therapeutics-receives-approval-by-centers-for-medicare--medicaid-services-pricing-data-analysis-and-coding-for-vidasleep-oral-appliance
Vivos Therapeutics Receives Approval By Ce...
07/01/2025 12:31:09

vivos-therapeutics-announces-european-journal-of-pediatrics-publishes-results-of-multicenter-clinical-trial-results-for-treatment-of-osa-in-children-using-vivos-patented-daytime-nighttime-appliance
Vivos Therapeutics Announces European Jour...
06/26/2025 12:32:11

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leader in proprietary, non-invasive treatm...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/20/2025 12:09:39

vivos-therapeutics-q1-eps-045-misses-040-estimate-sales-302m-miss-367m-estimate
Vivos Therapeutics Q1 EPS $(0.45) Misses $...
05/15/2025 20:15:51

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

vivos-therapeutics-signs-definitive-agreement-to-acquire-operating-assets-of-the-sleep-center-of-nevada-for-up-to-9m
Vivos Therapeutics Signs Definitive Agreem...
04/16/2025 12:31:15

ascendiant-capital-maintains-buy-on-vivos-therapeutics-lowers-price-target-to-62
Ascendiant Capital Maintains Buy on Vivos ...
04/15/2025 09:52:54

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and lowers the price target from...

vivos-therapeutics-fy-2024-gaap-eps-222-beats-225-estimate-sales-15000m-miss-15202m-estimate
Vivos Therapeutics FY 2024 GAAP EPS $(2.22...
03/31/2025 20:26:11

Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(2.22) per share which beat the analyst consensus estimate of $(...

earnings-scheduled-for-march-31-2025
Earnings Scheduled For March 31, 2025
03/31/2025 08:32:14

earnings-outlook-for-vivos-therapeutics
Earnings Outlook For Vivos Therapeutics
03/28/2025 17:03:02

vivos-therapeutics-announces-expansion-of-alliance-model-to-two-more-colorado-locations-as-sleep-apnea-patients-prefer-vivos-care-nearly-21-over-cpap-seeks-further-alliances-or-acquisitions-for-national-growth
Vivos Therapeutics Announces Expansion Of ...
02/24/2025 13:41:30

Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sl...

vivos-therapeutics-announces-35m-registered-direct-offering-of-709220-shares-of-common-stock-at-4935
Vivos Therapeutics Announces $3.5M Registe...
12/23/2024 13:04:38

Additional $3.4M Possible From Warrant Exercises

why-vision-marine-technologies-shares-are-trading-higher-by-34-here-are-20-stocks-moving-premarket
Why Vision Marine Technologies Shares Are ...
12/02/2024 11:29:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION